Fate of Biogen’s Stock Rides on Alzheimer’s Drug Decision – Yahoo Finance

(Bloomberg) — For Biogen Inc., the Food and Drug Administrations expected decision Monday on its Alzheimers drug is what a JPMorgan Chase & Co. analyst called the mother of all binary events — … [+3080 doodles em português]

Leave a Reply

Your email address will not be published. Required fields are marked *